MAIA Biotechnology

IN THE PRESS

BioMidwest

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement

March 26, 2024

·

4 min read

BioMidwest

MAIA Biotechnology Announces $1.33 Million Private Placement

March 26, 2024

·

4 min read

BioMidwest

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement

March 22, 2024

·

4 min read

Business

MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board

March 21, 2024

·

5 min read

BioMidwest

MAIA Biotechnology to Participate in the 36th Annual ROTH Conference

March 7, 2024

·

4 min read

BioMidwest

MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting

March 6, 2024

·

6 min read

Drug Development

MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients

March 6, 2024

·

6 min read

BioMidwest

MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders

March 5, 2024

·

4 min read

Business

MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor

February 27, 2024

·

6 min read

Drug Development

MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer

February 22, 2024

·

6 min read

JOBS